ABSCIENCES (EPA:AB) | Finanzwire

Basculer en Français

8609	Companies
141554	Keywords
77460	Articles
75647	Press releases

Home
Companies
ABSCIENCES

PRESS RELEASE

published on 06/28/2024 at 12:31, 9 months 12 days ago

AB Science provides an update on the application for conditional marketing authorisation of masitinib in ALS
AB Science receives negative opinion from CHMP on masitinib's conditional marketing authorization for ALS treatment but plans re-examination due to urgent patient need and safety considerations

AB Science Masitinib CHMP ALS Treatment Conditional Marketing Authorization
BRIEF

published on 06/27/2024 at 10:20, 9 months 13 days ago

AB Science - Results of the Combined General Meeting of June 26, 2024

Shareholders Share Capital Resolutions General Assembly AB Science
BRIEF

published on 05/17/2024 at 18:03, 10 months 24 days ago

Correction of the Consolidated Accounts of AB Science for 2023

Financial Results Research And Development Consolidated Accounts AB Science Accounting Correction
BRIEF

published on 05/15/2024 at 20:21, 10 months 26 days ago

Reduction in operational losses and significant advances in clinical development for AB Science in 2023

Financial Results Clinical Development AB Science Masitinib Amyotrophic Lateral Sclerosis
PRESS RELEASE

published on 05/15/2024 at 20:16, 10 months 26 days ago

AB Science reports its revenues for the year 2023 and provides an update on its activities
AB Science presents financial information for the year 2023, including clinical development updates and intellectual property strengthening. Consolidated operating loss decreased by 15.7% compared to 2022

Financial Information Clinical Development Intellectual Property Operating Loss AB Science

Accesswire

Published on 04/11/2025 at 02:40, 2 hours 9 minutes ago

McFarlane Lake Announces Closing of Final Tranche of Upsized $1.3 Million Private Placement Offering
Published on 04/11/2025 at 02:00, 2 hours 49 minutes ago

Battery X Metals Announces Formation of Critical Battery Metals Exploration Subsidiary and Expansion of Quebec Exploration Portfolio with Acquisition of 39 Additional Mineral Claims
Published on 04/11/2025 at 00:00, 4 hours 49 minutes ago

Onco-Innovations’ Inka Health Publishes Roche-Sponsored Study Advancing Real-World Oncology Research
Published on 04/10/2025 at 23:05, 5 hours 44 minutes ago

Caldwell Reports Second Quarter Results
Published on 04/10/2025 at 23:00, 5 hours 49 minutes ago

Highlander Silver Receives Conditional Approval to List on the TSX, Files Base Shelf Prospectus and Establishes ATM Program as Longer Term Financial Alternatives

View all ACCESSWIRE

EQS Group

Published on 04/10/2025 at 20:47, 8 hours 2 minutes ago

EQS-Adhoc: Hinkel & Cie. GmbH: first creditors´meeting of the bond DE000A2AAPX4
Published on 04/10/2025 at 20:44, 8 hours 5 minutes ago

EQS-Adhoc: artnet AG: artnet is in talks with two investors regarding a potential takeover offer
Published on 04/10/2025 at 19:00, 9 hours 49 minutes ago

Immunic, Inc. Announces Closing of $5.1 Million Registered Direct Offering, Led by Aberdeen Investments
Published on 04/10/2025 at 18:57, 9 hours 52 minutes ago

EQS-Adhoc: HAMBORNER REIT AG: Adjustment of dividend strategy
Published on 04/10/2025 at 18:28, 10 hours 21 minutes ago

Travis Perkins: Director/PDMR Shareholding

Les Echos

Published on 04/10/2025 at 17:45, 11 hours 4 minutes ago

EURAZEO INVESTS IN EKOSCAN INTEGRITY, A LEADING GLOBAL PROVIDER OF ADVANCED NON-DESTRUCTIVE TESTING SOLUTIONS FOR CRITICAL INDUSTRIAL APPLICATIONS AND INFRASTRUCTURE
Published on 04/10/2025 at 17:27, 11 hours 22 minutes ago

2024 URD - Universal Registration Document
Published on 04/09/2025 at 18:59, 1 day 9 hours ago

Description of the 2025-2026 Share Buyback Program
Published on 04/09/2025 at 18:57, 1 day 9 hours ago

Minutes of the Combined General Meeting held on April 9, 2025
Published on 04/09/2025 at 17:45, 1 day 11 hours ago

COGELEC : 2024 full-year results and Q1 2025 revenue.

View all LES ECHOS COMFI WIRE